2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)

  • ESC Sci Document Grp
  • , Frank L. J. Visseren
  • , Francois Mach
  • , Yvo M. Smulders
  • , David Carballo
  • , Konstantinos C. Koskinas
  • , Maria Back
  • , Athanase Benetos
  • , Alessandro Biffi
  • , Jose-Manuel Boavida
  • , Davide Capodanno
  • , Bernard Cosyns
  • , Carolyn Crawford
  • , Constantinos H. Davos
  • , Ileana Desormais
  • , Emanuele Di Angelantonio
  • , Oscar H. Franco
  • , Sigrun Halvorsen
  • , F. D. Richard Hobbs
  • , Monika Hollander
  • Ewa A. Jankowska, Matthias Michal, Simona Sacco, Naveed Sattar, Lale Tokgozoglu, Serena Tonstad, Konstantinos P. Tsioufis, Ineke van Dis, Isabelle C. van Gelder, Christoph Wanner, Bryan Williams

Research output: Contribution to journalArticleAcademicpeer-review

4833 Citations (Scopus)
2118 Downloads (Pure)
Original languageEnglish
Pages (from-to)3227-3337
Number of pages111
JournalEuropean Heart Journal
Volume42
Issue number34
DOIs
Publication statusPublished - 7-Sept-2021

Keywords

  • Guidelines
  • prevention
  • personalized
  • population
  • risk estimation
  • lifetime risk
  • lifetime benefit
  • risk management
  • shared decision-making
  • stepwise approach
  • nutrition
  • smoking
  • healthy lifestyle
  • psychosocial factors
  • blood pressure
  • lipids
  • diabetes
  • air pollution
  • climate change
  • CORONARY-HEART-DISEASE
  • OBSTRUCTIVE PULMONARY-DISEASE
  • ALL-CAUSE MORTALITY
  • TYPE-2 DIABETES-MELLITUS
  • ACUTE MYOCARDIAL-INFARCTION
  • CHRONIC KIDNEY-DISEASE
  • INDIVIDUAL-PARTICIPANT-DATA
  • PERIPHERAL ARTERY-DISEASE
  • BODY-MASS INDEX
  • DENSITY-LIPOPROTEIN CHOLESTEROL

Cite this